{
  "immunotherapy-checkpoint-patient.txt": "Immune checkpoint inhibitor therapy is a cancer immunotherapy that modulates T-cell response by blocking inhibitory signals (PD-1/PD-L1, CTLA-4, LAG-3), potentially triggering immune-related adverse events (irAEs) affecting multiple organ systems through autoimmune-like mechanisms. Side effects range from mild to life-threatening immunological toxicities requiring immunosuppressive intervention.",
  "ctcl-patient.txt": "Cutaneous T-cell lymphoma is a neoplastic lymphoproliferative disorder characterized by malignant T-lymphocyte infiltration of epidermis and dermis. This hematologic malignancy primarily manifests in cutaneous tissues but can disseminate to lymph nodes, peripheral blood, and visceral organs, causing immunological dysfunction and lymphadenopathy.",
  "Mantle-patient-guideline.txt": "Mantle cell lymphoma is a malignant neoplasm of B-lymphocytes originating in the mantle zone of lymphoid follicles, characterized by cyclin D1 overexpression and t(11;14) chromosomal translocation. This aggressive non-Hodgkin lymphoma typically presents with lymphadenopathy, extranodal involvement, and systemic dissemination through lymphatic circulation.",
  "survivorship-hl-patient.txt": "Cancer survivorship encompasses post-diagnostic medical sequelae, requiring comprehensive longitudinal care management. This condition involves monitoring for disease recurrence, surveillance of treatment-related morbidities, management of late-onset complications, preventive health maintenance, and coordination of multidisciplinary interventions to optimize physiological and psychosocial outcomes in cancer survivors.",
  "hn-nasopharynx-patient.txt": "Nasopharyngeal carcinoma (NPC) is a malignant neoplasm originating in squamous epithelial cells of the nasopharyngeal mucosa, anatomically situated posterior to the nasal cavity and superior to the oropharynx. This rare epithelial malignancy demonstrates distinct geographic epidemiology, with predominant occurrence in Asian populations.",
  "thyroid-patient.txt": "Thyroid cancer encompasses neoplastic proliferation of thyroid follicular cells, presenting as nodular growths within the thyroid parenchyma. Malignant transformation can affect differentiated thyrocytes, producing papillary, follicular, or oncocytic variants, or arise from parafollicular C-cells causing medullary carcinoma. Anaplastic dedifferentiation represents aggressive phenotype.",
  "esophageal-patient.txt": "Esophageal cancer is a malignant neoplasm originating in the mucosal epithelium of the esophageal wall, potentially infiltrating through submucosal, muscular, and adventitial layers. It commonly presents as either squamous cell carcinoma or adenocarcinoma, with potential for lymphatic metastasis and hematogenous dissemination to distant organs.",
  "aya-patient.txt": "Adolescent and Young Adult (AYA) cancer encompasses malignancies occurring between ages 15-39, characterized by unique oncologic presentations, distinct tumor biology, age-specific treatment responses, psychosocial complexities, and specialized therapeutic considerations regarding fertility preservation, endocrine function, and long-term survivorship care needs.",
  "inflammatory-breast-patient.txt": "Inflammatory breast cancer is an aggressive mammary carcinoma characterized by lymphatic invasion and obstruction within dermal tissue, manifesting with erythema, edema, and induration of breast parenchyma. This invasive ductal carcinoma variant presents with rapid-onset cutaneous lymphangitic spread, causing characteristic peau d'orange appearance and warmth.",
  "immunotherapy-se-car-tcell-patient.txt": "Chimeric antigen receptor (CAR) T-cell therapy is an immunotherapeutic modality involving genetic modification of autologous T-lymphocytes to express tumor-targeting CARs. Following lymphodepleting chemotherapy, engineered cells are reinfused, potentially triggering cytokine release syndrome, immune effector cell-associated neurotoxicity syndrome (ICANS), and hemophagocytic lymphohistiocytosis-like syndrome",
  "uterine-patient.txt": "Uterine cancer encompasses malignant neoplasms originating in endometrial or myometrial tissue. Primary variants include endometrial carcinoma arising from endometrial epithelium and uterine sarcomas developing in myometrial mesenchymal tissue. Manifestations include postmenopausal metrorrhagia, abnormal uterine bleeding, and metastatic spread through lymphovascular invasion.",
  "anemia-patient-guideline.txt": "Anemia and neutropenia are hematologic disorders characterized by deficiencies in erythrocytes and neutrophils respectively. Erythropenia causes decreased oxygen-carrying capacity, while neutropenia impairs immunological defense against pathogens. Both conditions can result from myelosuppression, bone marrow dysfunction, cytotoxic chemotherapy, or hematopoietic disorders.",
  "sarcoma-patient.txt": "Soft tissue sarcoma encompasses malignant mesenchymal neoplasms originating in connective tissues, including adipocytic, myogenic, neurogenic, and fibroblastic elements. These heterogeneous neoplasms predominantly affect musculoskeletal structures, with anatomic predilection for extremities and retroperitoneum, demonstrating varying degrees of histopathologic differentiation and metastatic potential.",
  "stage_0_breast-patient.txt": "Ductal carcinoma in situ (DCIS) is a noninvasive neoplastic proliferation confined within the mammary ductal system, characterized by malignant epithelial cells that have not penetrated the basement membrane or invaded surrounding stromal tissue. This stage 0 preinvasive lesion represents a precursor to invasive ductal carcinoma.",
  "mpm-patient.txt": "Malignant pleural mesothelioma is a rare neoplastic malignancy originating in the mesothelial cells of the pleural membrane, comprising both visceral and parietal layers surrounding the lungs. This aggressive thoracic malignancy infiltrates pleural tissue, causing pleural effusion and progressive respiratory compromise.",
  "lung_screening-patient.txt": "Lung cancer encompasses malignant neoplasms originating in bronchial epithelial cells, primarily categorized as non-small cell lung carcinoma (NSCLC) or small cell lung carcinoma (SCLC). NSCLC includes adenocarcinoma, squamous cell carcinoma, and large cell carcinoma subtypes. Neoplastic transformation occurs in bronchial, bronchiolar, or alveolar tissues",
  "bladder-patient.txt": "Bladder cancer is a malignant neoplasm originating in urothelial cells of the vesical mucosa, characterized by uncontrolled cellular proliferation and potential muscular invasion. This uroepithelial carcinoma exhibits high recurrence rates, presents with hematuria, and can progress from non-muscle-invasive to muscle-invasive disease with metastatic potential.",
  "fatigue-patient.txt": "Cancer-related fatigue is a multifactorial pathophysiological condition characterized by persistent physical, emotional, and cognitive exhaustion unrelieved by rest. This treatment-refractory symptomatology disrupts activities of daily living, persisting post-treatment with significant psychosocial morbidity, often complicated by concurrent medical conditions affecting energy homeostasis.",
  "breastcancerscreening-patient.txt": "Here's a 50-word medical description of breast cancer based on the document:\n\nA malignant neoplastic disease originating in mammary epithelial cells and ductal-lobular structures, characterized by abnormal cellular proliferation within breast tissue. The disease can metastasize via lymphatic vessels to axillary lymph nodes. Early detection through screening of asymptomatic individuals enables identification during initial, more treatable stages.",
  "colon-patient.txt": "Colon cancer is a malignant adenocarcinoma typically arising from adenomatous polyps in the colonic mucosa. This neoplastic transformation occurs through sequential mutations, often involving mismatch repair deficiency (dMMR). The disease can progress from localized to metastatic stages, affecting regional lymph nodes and distant organs.",
  "systemic-mastocytosis-patient-guideline.txt": "Systemic mastocytosis is a hematopoietic neoplasm characterized by pathological proliferation and accumulation of neoplastic mast cells in multiple organ systems, particularly bone marrow. The condition involves KIT D816V mutations, causing aberrant mast cell activation with release of inflammatory mediators including histamine, prostaglandins, and cytokines.",
  "bloodclots-patient.txt": "Cancer-associated venous thromboembolism involves pathological blood clot formation within vessels, characterized by platelet aggregation, fibrin mesh development, and potential embolization. This thromboembolic condition frequently manifests in malignancy due to hypercoagulable states, vascular endothelial dysfunction, systemic inflammation, and treatment-related factors including chemotherapy, surgery, and central venous catheterization.",
  "nausea-patient.txt": "Nausea and vomiting are autonomic gastrointestinal reflexes triggered by toxic substances, characterized by gastric expulsion and emetic response. These chemotherapy-induced or radiation-induced symptoms involve vestibular stimulation, neurotransmitter activation, and chemoreceptor trigger zone stimulation, potentially causing dehydration and electrolyte imbalances requiring antiemetic prophylaxis.",
  "colorectal-screening-patient.txt": "Colorectal cancer is a malignant neoplasm originating in the colonic or rectal mucosa, typically developing from adenomatous polyps through dysplastic transformation. The adenoma-carcinoma sequence progresses through the bowel wall layers, beginning in the mucosal epithelium, potentially advancing to invasive adenocarcinoma with metastatic potential.",
  "genetics-patient.txt": "Hereditary cancer syndromes are germline genetic disorders characterized by inherited pathogenic variants in cancer predisposition genes, affecting breast, ovarian, pancreatic, and prostate tissues. These syndromes demonstrate variable penetrance, with high-penetrance variants conferring greater cancer susceptibility. Environmental and lifestyle factors modulate phenotypic expression.",
  "neuroendocrine-patient.txt": "Neuroendocrine tumors are neoplastic growths arising from specialized cells of the neuroendocrine system, characterized by hormone-secreting capabilities and variable differentiation. These malignancies can develop throughout the body's endocrine and nervous systems, demonstrating heterogeneous morphology, proliferation rates, and metastatic potential.",
  "hn-oral-patient.txt": "Oral cavity cancer is a malignant neoplasm affecting squamous epithelium of the buccal mucosa, maxillary and mandibular alveolar ridges, gingiva, anterior two-thirds of tongue, retromolar trigone, hard palate, and labial mucosa, with potential for submucosal invasion and metastasis through lymphatic vessels.",
  "nhl-follicular-patient.txt": "Follicular lymphoma is an indolent B-cell non-Hodgkin lymphoma characterized by neoplastic proliferation of mature B lymphocytes forming abnormal follicular patterns within lymphoid tissues. Malignant cells originate from germinal center B-cells, typically presenting with lymphadenopathy and potential extranodal involvement. Disease exhibits characteristic immunophenotypic and cytogenetic features.",
  "distress-patient.txt": "Psychosocial oncological distress manifests as an unpleasant biopsychosocial and spiritual experience affecting cancer patients, characterized by psychological, physical, social, and existential symptoms. This multidimensional condition ranges from mild to severe, impacting cognition, emotional regulation, behavioral patterns, interpersonal functioning, and treatment adherence.",
  "stage_iv_breast-patient.txt": "Metastatic breast cancer is a malignant neoplasm originating in mammary epithelial cells that disseminates hematogenously or lymphatically beyond primary site, establishing secondary carcinomatous lesions in distant organs, commonly affecting osseous structures, pulmonary tissue, hepatic parenchyma, cerebral matter, and distant lymph nodes.",
  "prostate-early-patient.txt": "Prostate adenocarcinoma is a malignant neoplasm originating in prostatic epithelial cells, characterized by abnormal cellular proliferation within the prostate gland. Initially asymptomatic, this androgen-dependent malignancy can progress through local invasion and metastasis, potentially affecting lymph nodes and osseous structures. Early detection enables curative intervention.",
  "stomach-patient.txt": "Gastric adenocarcinoma is a malignant neoplasm originating in the gastric mucosa, characterized by abnormal epithelial cell proliferation. Disease progression involves transmural invasion through muscularis propria, subserosal, and serosal layers, with potential lymphovascular invasion, nodal metastasis, and distant organ dissemination via hematogenous spread.",
  "melanoma-patient.txt": "Melanoma is a malignant neoplasm originating from melanocytes in the epidermal basal layer, characterized by abnormal melanin production and potential dermal invasion. This cutaneous malignancy exhibits metastatic potential through lymphatic and hematogenous spread, with UV radiation exposure being a significant carcinogenic factor.",
  "pcnsl-patient.txt": "Primary CNS lymphoma is an aggressive neoplasm originating in lymphocytes within the central nervous system, predominantly affecting cerebral tissue, with potential dissemination to leptomeninges, cerebrospinal fluid, and ocular structures. This immunoproliferative malignancy rarely metastasizes extraneurally but can cause significant neurologic morbidity.",
  "gallandbile-hp-patient.txt": "Gallbladder and bile duct cancers are malignant neoplasms affecting the hepatobiliary system, including intrahepatic and extrahepatic biliary structures. These adenocarcinomas can arise in the gallbladder or cholangiocarcinomas can develop in bile ducts, potentially causing biliary obstruction, cholestasis, and hepatic dysfunction.",
  "waldenstrom-patient.txt": "Waldenstr\u00f6m macroglobulinemia is an indolent lymphoplasmacytic lymphoma originating in bone marrow, characterized by malignant B-lymphocytes exhibiting both lymphocytic and plasmacytic differentiation. It produces excessive monoclonal IgM immunoglobulin, causing hyperviscosity syndrome and cytopenias through marrow infiltration.",
  "ped_all_patient.txt": "Pediatric acute lymphoblastic leukemia is a hematologic malignancy characterized by rapid proliferation of immature lymphoid progenitor cells (lymphoblasts) in bone marrow, disrupting normal hematopoiesis. This neoplastic transformation affects lymphoid stem cell differentiation, causing pancytopenia and immune dysfunction through marrow infiltration.",
  "squamous_cell-patient.txt": "Cutaneous squamous cell carcinoma (CSCC) is a keratinocyte carcinoma originating in epidermal squamous cells, characterized by neoplastic transformation of keratinocytes. This malignancy typically presents as hyperkeratotic lesions with potential for local invasion, metastasis to lymph nodes, and dermal infiltration through basement membrane disruption.",
  "prostate-advanced-patient.txt": "Advanced prostate cancer is a malignant neoplasm originating in prostatic epithelial cells, characterized by uncontrolled cellular proliferation, potential metastatic dissemination, and PSA elevation. Disease progression may involve extraprostatic extension, lymph node involvement, and distant metastases, particularly osteoblastic bone lesions.",
  "survivorship-crl-patient.txt": "Cancer survivorship encompasses post-diagnostic sequelae, including acute and chronic treatment-related morbidities, psychosocial complications, and long-term physiological effects. This comprehensive condition requires ongoing surveillance for secondary malignancies, management of treatment-induced organ dysfunction, monitoring of endocrine abnormalities, and addressing neurocognitive deficits, cardiotoxicity, lymphedema, and other systemic manifestations.",
  "CBCL-patient.txt": "Cutaneous B-cell lymphoma (CBCL) is a lymphoproliferative neoplasm originating from malignant B-lymphocytes in cutaneous tissue. This non-Hodgkin lymphoma subtype manifests as dermal/subcutaneous nodules or papules, primarily affecting skin without systemic involvement. B-cells produce immunoglobulins and participate in humoral immunity.",
  "hn-oropharyngeal-patient.txt": "Throat cancer primarily affects the oropharyngeal region, manifesting as malignant neoplasms in squamous epithelium of the soft palate, palatine tonsils, pharyngeal walls, and tongue base. Often HPV-associated, these carcinomas can present with lymphatic metastasis, dysphagia, odynophagia, and oropharyngeal mass lesions.",
  "mzl-patient.txt": "Marginal zone lymphoma (MZL) is an indolent B-cell non-Hodgkin lymphoma originating from marginal zone B-lymphocytes in lymphoid tissues. Characterized by neoplastic proliferation of abnormal B-cells, MZL can manifest in extranodal sites, lymph nodes, or splenic tissue. Associated with chronic inflammation, autoimmune disorders, and lymphoid hyperplasia.",
  "basal-cell-patient-guideline.txt": "Basal cell carcinoma is a malignant neoplasm originating in epidermal basal keratinocytes, characterized by uncontrolled proliferation of these cells within cutaneous tissue. This carcinoma typically presents with local invasiveness, dermal infiltration, and UV-induced mutations, demonstrating variable histopathological patterns and potential for local tissue destruction.",
  "liver-hp-patient.txt": "Hepatocellular carcinoma is a primary malignant neoplasm arising from hepatocytes, characterized by abnormal cellular proliferation within hepatic parenchyma. This malignancy can develop in cirrhotic or non-cirrhotic liver, often associated with viral hepatitis, steatohepatitis, or cirrhosis, potentially leading to portal hypertension and hepatic decompensation.",
  "lung-metastatic-patient.txt": "Metastatic non-small cell lung carcinoma is a malignant neoplasm originating in bronchial, bronchiolar, or alveolar epithelium, characterized by uncontrolled cellular proliferation and metastatic dissemination beyond primary pulmonary sites. Common histologic variants include adenocarcinoma, squamous cell carcinoma, and large cell carcinoma.",
  "bone-patient.txt": "Primary bone cancer encompasses malignant neoplasms originating in osseous or cartilaginous tissue, including osteosarcoma, chondrosarcoma, chordoma, and Ewing sarcoma. These sarcomas typically arise in metaphyseal regions, affecting long bones, pelvis, or vertebrae, with distinct histopathological features differentiating them from metastatic bone malignancies.",
  "cll-patient.txt": "Chronic lymphocytic leukemia is a hematologic malignancy characterized by clonal proliferation of abnormal B-lymphocytes in bone marrow, peripheral blood, and lymphoid tissues. This indolent neoplasm causes myelosuppression, lymphocytosis, and immunodeficiency, leading to pancytopenia, recurrent infections, and lymphadenopathy.",
  "cml-patient.txt": "Chronic myeloid leukemia is a myeloproliferative neoplasm characterized by clonal expansion of transformed hematopoietic stem cells expressing BCR::ABL1 fusion oncogene, resulting in excessive granulocyte production. The Philadelphia chromosome translocation t(9;22) drives aberrant myeloid differentiation and leukemic transformation of bone marrow progenitors.",
  "adrenal-patient.txt": "Adrenal tumors are neoplastic growths affecting the adrenal cortex or medulla, disrupting endocrine function through abnormal hormone production. These lesions can secrete excess cortisol, aldosterone, catecholamines, or androgens, manifesting as distinct endocrine syndromes including Cushing's, Conn's, or pheochromocytoma with associated metabolic and cardiovascular complications.",
  "palliative-patient.txt": "Palliative care is a comprehensive medical intervention focusing on symptom management, psychosocial support, and quality-of-life optimization for patients with serious illnesses. It encompasses pain control, psycho-oncological support, multidisciplinary care coordination, advance care planning, and therapeutic interventions for physical and psychological symptom amelioration throughout disease progression.",
  "brain-gliomas-patient.txt": "Gliomas are malignant neoplasms originating from glial cells within the central nervous system, characterized by infiltrative growth patterns into surrounding neural tissue. These neuroepithelial tumors demonstrate varying degrees of cellular differentiation, mitotic activity, and molecular alterations, manifesting as astrocytomas, oligodendrogliomas, or glioblastomas with distinct histopathological features.",
  "kidney-patient.txt": "Renal cell carcinoma (RCC) is a malignant neoplasm originating in renal tubules, characterized by aberrant cellular proliferation within nephrons. This adenocarcinoma exhibits various histological subtypes, potential metastatic dissemination via lymphatics and vasculature, and can infiltrate perirenal tissues through the renal capsule into Gerota's fascia.",
  "small-bowel-patient.txt": "Small bowel adenocarcinoma is a malignant neoplasm originating in mucus-secreting epithelial cells of the intestinal mucosa, predominantly affecting the duodenum. This gastrointestinal malignancy can cause bowel obstruction, gastrointestinal hemorrhage, iron-deficiency anemia, and metastasizes through lymphatic and hematogenous routes. Associated risk factors include inflammatory bowel disease and hereditary cancer",
  "mpn-patient.txt": "Myeloproliferative neoplasms are hematopoietic stem cell disorders characterized by clonal proliferation of myeloid lineage cells, resulting in overproduction of erythrocytes, leukocytes, or megakaryocytes. These chronic neoplasms can manifest with thrombocytosis, erythrocytosis, leukocytosis, bone marrow fibrosis, and thrombohemorrhagic",
  "ovarian-patient.txt": "Ovarian cancer is a malignant neoplasm primarily affecting ovarian epithelium, with high-grade serous carcinoma and endometrioid carcinoma being predominant histological subtypes. Metastasis frequently involves peritoneal dissemination. Associated pathology may include fallopian tube involvement, peritoneal carcinomatosis, and less common histological variants affecting stromal or germ cell components.",
  "all-patient.txt": "Acute lymphoblastic leukemia is a hematologic malignancy characterized by aberrant proliferation of immature lymphoid progenitors (lymphoblasts) in bone marrow, causing myelosuppression with subsequent pancytopenia. This aggressive neoplasm disrupts normal hematopoiesis and can infiltrate extramedullary sites, requiring urgent cytotoxic intervention.",
  "anal-patient.txt": "Anal cancer is a malignant neoplasm primarily manifesting as squamous cell carcinoma originating in anal canal epithelium or perianal tissue. This gastrointestinal malignancy affects anorectal squamous mucosa, with potential for local invasion, lymphatic spread, and metastasis. HPV infection frequently contributes to carcinogenesis.",
  "SCLC-patient-guideline.txt": "Small cell lung cancer (SCLC) is a highly aggressive neoplasm originating in bronchial epithelial cells, characterized by rapid proliferation, early metastatic dissemination, and neuroendocrine differentiation. The malignancy exhibits microscopic features of small, round cells with scant cytoplasm, nuclear molding, and frequent lymphovascular invasion.",
  "aml-patient.txt": "Acute myeloid leukemia is a hematologic malignancy originating in hematopoietic stem cells within bone marrow, characterized by abnormal myeloblast proliferation and impaired differentiation, disrupting normal hematopoiesis and causing deficiencies in erythrocytes, granulocytes, and thrombocytes, leading to pancytopenia and bone marrow failure.",
  "mds-patient.txt": "Myelodysplastic syndromes (MDS) are clonal hematopoietic stem cell disorders characterized by ineffective hematopoiesis, dysplastic morphology, cytopenia, medullary dysplasia, and potential transformation to acute myeloid leukemia. Abnormal myeloblasts proliferate in bone marrow, disrupting normal erythropoiesis, myelopoiesis, and throm",
  "quitting-smoking-patient.txt": "Nicotine dependence is a neurophysiological addiction characterized by compulsive tobacco use, neuroadaptive changes, withdrawal symptomatology, and systemic health impacts. The condition involves dopaminergic pathway alterations, compromised therapeutic responses in oncology, increased surgical complications, elevated infection risks, and impaired cardiopulmonary function.",
  "pancreatic-patient.txt": "Pancreatic adenocarcinoma is a malignant neoplasm originating in exocrine ductal epithelium of the pancreas, characterized by uncontrolled cellular proliferation, local tissue invasion, and metastatic potential. This adenocarcinoma disrupts both endocrine and exocrine pancreatic functions, affecting digestive enzyme production and glucose homeostasis.",
  "myeloma-patient.txt": "Multiple myeloma is a hematologic malignancy characterized by neoplastic proliferation of monoclonal plasma cells in bone marrow, producing pathologic immunoglobulins (M-proteins). This myeloproliferative disorder causes osteolytic lesions, medullary infiltration, cytopenia, hypercalcemia, and end-organ damage through paraprotein deposition and immunosuppression.",
  "nhl-diffuse-patient.txt": "Diffuse large B-cell lymphoma (DLBCL) is an aggressive hematologic malignancy originating from abnormal B-lymphocytes in lymphoid tissue. This neoplastic disorder manifests with diffuse proliferation of large lymphoid cells, affecting lymph nodes, bone marrow, spleen, and extranodal sites, often presenting with constitutional symptoms and lymphadenopathy.",
  "lung-early-stage-patient.txt": "Non-small cell lung carcinoma (NSCLC) is a malignant neoplasm originating from bronchial epithelial cells, predominantly presenting as adenocarcinoma or large cell carcinoma. The neoplastic cells exhibit uncontrolled proliferation within pulmonary parenchyma, with potential lymphatic metastasis to hilar and mediastinal nodes in early and locally advanced stages.",
  "cervical-patient-guideline.txt": "Cervical cancer is a malignant neoplasm originating in the squamo-columnar junction of the cervix, predominantly affecting squamous epithelial cells. Human papillomavirus infection triggers cellular transformation, causing dysplastic changes progressing through intraepithelial neoplasia to invasive carcinoma, potentially metastasizing through parametrial and lymphovascular routes.",
  "hodgkinlymphomainchildren-patient.txt": "Hodgkin lymphoma is a malignant neoplasm of lymphoid tissue characterized by abnormal lymphocyte proliferation, particularly Reed-Sternberg cells, affecting lymph nodes and lymphatic system. Disease presents with lymphadenopathy, potential extranodal involvement, and systemic symptoms. Two major histologic variants exist: classical and nodular lymphocyte-predominant.",
  "breast-invasive-patient.txt": "Invasive breast carcinoma is a malignant neoplasm originating in epithelial cells of terminal duct lobular units, characterized by metastatic potential through lymphovascular invasion. Primary tumors penetrate beyond ducts/lobules into surrounding mammary stroma, with possible axillary lymph node involvement and distant metastases to osseous, pulmonary, hepatic, or cerebral sites.",
  "GVDH-patient-guideline.txt": "Graft-versus-host disease is an immunological complication following allogeneic hematopoietic stem cell transplantation, characterized by donor lymphocyte-mediated attack on recipient tissues. Manifestations include cutaneous, gastrointestinal, and hepatic inflammation, with potential multisystem involvement causing significant morbidity through acute and chronic pathophysiological mechanisms.",
  "PTCL-patient-guideline.txt": "Peripheral T-cell lymphoma is a rare hematologic malignancy originating from mature T-lymphocytes in the lymphatic system. This aggressive neoplasm can manifest throughout lymphoid tissues, including nodal and extranodal sites, causing lymphadenopathy, splenomegaly, and systemic immunologic dysfunction.",
  "gist-patient.txt": "Gastrointestinal stromal tumors (GIST) are mesenchymal neoplasms originating in interstitial cells of Cajal within gastrointestinal tract walls, predominantly affecting stomach and small intestine. These sarcomas exhibit variable malignant potential, from indolent microlesions to aggressive metastatic tumors with hepatic and peritoneal dissemination."
}
